Back
Ono Pharmaceutical Vs. Nxera Pharma Industry Stock Comparison
Sell
37
OPHLY
Ono Pharmaceutical
Last Price:
4.86
Seasonality Move:
-1.48%
Sell
38
SOLTF
Nxera Pharma
Last Price:
9.82
Seasonality Move:
21.23%
Sell
37
Ono Pharmaceutical (OPHLY)
is a Sell
Is Ono Pharmaceutical a Buy, Sell or Hold?
- The current Ono Pharmaceutical [OPHLY] share price is $4.86. The Score for OPHLY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- OPHLY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Nxera Pharma (SOLTF)
is a Sell
Is Nxera Pharma a Buy, Sell or Hold?
- The current Nxera Pharma [SOLTF] share price is $9.82. The Score for SOLTF is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- SOLTF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
OPHLY Stock Price Chart
What is Ono Pharmaceutical's stock price today?
-
The Ono Pharmaceutical share price today is $4.86
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OPHLY is experiencing slight buying pressure.
SOLTF Stock Price Chart
What is Nxera Pharma's stock price today?
-
The Nxera Pharma share price today is $9.82
The current trend is relatively stagnant and SOLTF is experiencing slight buying pressure.
OPHLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 39.97 | Sell |
| Chaikin Money Flow: | 24147 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.81 - 5.11) | Sell |
| Bollinger Bands (100): | (5.11 - 5.83) | Sell |
SOLTF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 51.77 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.39 - 10.19) | Buy |
| Bollinger Bands (100): | (9.24 - 10.8) | Sell |
OPHLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.9 | Sell |
| 20-day SMA: | 4.89 | Sell |
| 50-day SMA: | 5.21 | Sell |
| 200-day SMA: | 5.8 | Sell |
| 8-day EMA: | 4.89 | Sell |
| 20-day EMA: | 4.95 | Sell |
| 50-day EMA: | 5.15 | Sell |
| 200-day EMA: | 5.75 | Sell |
SOLTF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.55 | Buy |
| 20-day SMA: | 9.63 | Buy |
| 50-day SMA: | 10.19 | Sell |
| 200-day SMA: | 10.22 | Sell |
| 8-day EMA: | 9.63 | Buy |
| 20-day EMA: | 9.7 | Buy |
| 50-day EMA: | 9.9 | Sell |
| 200-day EMA: | 10.81 | Sell |
Ono Pharmaceutical Earnings Growth & OPHLY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nxera Pharma Earnings Growth & SOLTF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ono Pharmaceutical Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nxera Pharma Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||